Published in Br Med J (Clin Res Ed) on April 09, 1983
Early identification of refractory epilepsy. N Engl J Med (2000) 12.43
Cancer statistics, 2000. CA Cancer J Clin (2000) 12.32
Cancer statistics, 2001. CA Cancer J Clin (2001) 11.73
Cancer statistics, 1999. CA Cancer J Clin (1999) 9.18
Cancer statistics, 1998. CA Cancer J Clin (1998) 6.26
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res (1999) 3.24
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia (1999) 2.29
Epilepsy after the first drug fails: substitution or add-on? Seizure (2000) 2.19
New antiepileptic drugs. N Engl J Med (1996) 2.04
Systems and strategies for managing the drugs budget in Glasgow. BMJ (1998) 2.01
Effectiveness of first antiepileptic drug. Epilepsia (2001) 1.94
Hereditary coproporphyria. Demonstration of the abnormalities in haem biosynthesis in peripheral blood. Q J Med (1977) 1.91
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand (2003) 1.90
Differential induction of antipyrine metabolism by rifampicin. Eur J Clin Pharmacol (1981) 1.81
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
High incidence of lichen sclerosus in patients with squamous cell carcinoma of the penis. Br J Dermatol (2001) 1.77
Carbamazepine substitution in severe partial epilepsy: implication of autoinduction of metabolism. Postgrad Med J (1985) 1.77
Mixed function oxidase activity in microsomal fractions of human liver biopsy specimens [proceedings]. Br J Clin Pharmacol (1978) 1.75
Multiple myeloma and the anion gap. N Engl J Med (1975) 1.72
Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. Br J Clin Pharmacol (1980) 1.69
Lung cancer after radiation therapy for breast cancer. Cancer (1993) 1.68
Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers. Cancer (1994) 1.67
Epilepsy in elderly people. Lancet (2000) 1.64
Rationale, design and methods of the HEALTHY study physical education intervention component. Int J Obes (Lond) (2009) 1.61
Inhaled fentanyl as a method of analgesia. Anaesthesia (1990) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Dietary risk factors for the incidence and recurrence of colorectal adenomatous polyps. A case-control study. Ann Intern Med (1993) 1.58
Managing seizures in the casualty department. BMJ (1990) 1.58
Do parents and professionals agree on the developmental status of high-risk infants? Pediatrics (1996) 1.56
Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. J Neurol Neurosurg Psychiatry (2003) 1.53
Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther (1981) 1.52
New antiepileptic drugs. The drugs are not all the same. BMJ (1997) 1.51
Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia (2001) 1.48
Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet (2001) 1.48
Which electroencephalography (EEG) for epilepsy? The relative usefulness of different EEG protocols in patients with possible epilepsy. J Neurol Neurosurg Psychiatry (2006) 1.48
Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver. Br J Clin Pharmacol (1981) 1.47
An internally-standardized assay for amphotericin B in tissues and plasma. J Chromatogr (1983) 1.46
Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions. Br J Dermatol (2013) 1.46
Genetic testing for cancer risk: how to reconcile the conflicts. JAMA (1998) 1.42
DRESS syndrome caused by efalizumab. Clin Exp Dermatol (2007) 1.42
Fatal falciparum malaria and the availability of parenteral antimalarial drugs in hospitals. Br Med J (Clin Res Ed) (1982) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Epididymal specific, selenium-independent GPX5 protects cells from oxidative stress-induced lipid peroxidation and DNA mutation. Hum Reprod (2013) 1.41
Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid. J Nucl Med (1988) 1.41
Differences in histology between first and second primary lung cancer. Cancer Epidemiol Biomarkers Prev (1993) 1.41
The effect of verapamil on the pharmacokinetics of adriamycin. Cancer Chemother Pharmacol (1986) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Diagnosing refractory epilepsy: response to sequential treatment schedules. Eur J Neurol (2006) 1.36
Visual field constriction: accumulation of vigabatrin but not tiagabine in the retina. Neurology (2001) 1.36
Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction. Lancet (1986) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man. Br J Clin Pharmacol (1981) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Hemodynamic effects of oral smokeless tobacco in dogs and young adults. Prev Med (1984) 1.31
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
Sudden unexplained death in epilepsy: observations from a large clinical development program. Epilepsia (1997) 1.29
The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther (2001) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Antiepileptic drug monitoring at the epilepsy clinic: a prospective evaluation. Epilepsia (1991) 1.24
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
Chronic interstitial nephritis: etiologic factors. Ann Intern Med (1975) 1.21
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Concentration--effect and concentration--toxicity relations with lamotrigine: a prospective study. Epilepsia (1996) 1.19
Effects of cimetidine on carbamazepine auto- and hetero-induction in man. Br J Clin Pharmacol (1984) 1.19
Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine. Br J Clin Pharmacol (1983) 1.17
Sudden death in epilepsy: an avoidable outcome? J R Soc Med (1992) 1.17
Therapeutic drug monitoring--the need for audit? Scott Med J (1985) 1.16
Is prostacyclin in the major pro-inflammatory prostanoid in joint fluid? Life Sci (1980) 1.14
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med (1979) 1.12
Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. Eur J Clin Pharmacol (1981) 1.12
Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12
A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res (1997) 1.12
Drug metabolism in white vegetarians. Br J Clin Pharmacol (1980) 1.12
Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients. J Neurol Neurosurg Psychiatry (1988) 1.11
First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11
A crossover, add-on trial of talampanel in patients with refractory partial seizures. Neurology (2002) 1.10
Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther (1982) 1.10
Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants. Br J Clin Pharmacol (1983) 1.09
CT, MR and SPECT imaging in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (1990) 1.09
Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab (1995) 1.08
Streptokinase and serum enzymes. Br Med J (1976) 1.08
Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08
Management of epilepsy during pregnancy and lactation. Lancet (1990) 1.07
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
Recurrent subarachnoid bleeding in association with dural substitute. Report of three cases. J Neurosurg (1984) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. Br J Cancer (1991) 1.07
Antipyrine elimination as a dynamic test of hepatic functional integrity in obstructive jaundice. Gut (1982) 1.07
Data on results of using different antiepileptic drugs do exist. BMJ (1997) 1.07
Amino acid sequences of peptides from a tryptic digest of a urea-soluble protein fraction (U.S.3) from oxidized wool. Biochem J (1967) 1.06
Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06
Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients. Br J Cancer (2003) 1.05
Cognitive function in adult epileptic patients established on anticonvulsant monotherapy. Epilepsy Res (1990) 1.05
Bone density and antiepileptic drugs: a case-controlled study. Seizure (1999) 1.05
Drug metabolism in liver disease. Pharmacol Ther (1989) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05